Evidence map›Paper›PMID 30084961›Full record

ArticleBiology of reproduction2019

Bone marrow-derived cells or C-X-C motif chemokine 12 (CXCL12) treatment improve thin endometrium in a mouse model.

Kyong Wook Yi, Ramanaiah Mamillapalli, Cagdas Sahin, Jaeyen Song, Reshef Tal, Hugh S Taylor

Open access · bronzeAbstract read
In one paragraph

Article in Biology of reproduction, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Regulation and Function of Chemokines at the Maternal-Fetal Interface.Frontiers in cell and developmental biology · 2022
    Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Kyong Wook YiDepartment of Obstetrics and Gynecology, Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut, USA.
Ramanaiah MamillapalliDepartment of Obstetrics and Gynecology, Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut, USA.
Cagdas SahinDepartment of Obstetrics and Gynecology, Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut, USA.
Jaeyen SongDepartment of Obstetrics and Gynecology, Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut, USA.
Reshef TalDepartment of Obstetrics and Gynecology, Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut, USA.
Hugh S TaylorDepartment of Obstetrics and Gynecology, Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut, USA.
Yale University · USKorea University · KR

Funding

The Yale WRHR Career Development CenterK12HD047018 · NICHD · YALE UNIVERSITY · PI Hugh Smith Taylor · 2004 to 2026
$7.8M
Tissue Factor and EmdometriosisU54HD052668 · NICHD · YALE UNIVERSITY · PI TAYLOR, HUGH SMITH · 2007 to 2011
$6.6M
NICHD NIH HHS K12 HD047018NICHD NIH HHS U54 HD052668
6 · The paper itself

Abstract

Successful implantation and pregnancy is dependent on sufficient endometrial growth during each reproductive cycle. Here, we report the therapeutic effect of either bone marrow-derived cells (BMDCs) or the stem cell chemo-attractant C-X-C motif chemokine 12 (CXCL12) on endometrial receptivity in a murine ethanol induced thin endometrium model. Endometrial epithelial area was significantly increased in mice treated with BMDCs, CXCL12, or by co-treatment with both compared with PBS-treated controls. Ki-67 and CD31 immunoreactivity was significantly higher in mice treated with either BMDCs, CXCL12, or both. The mRNA expression levels of endometrial receptivity markers leukemia inhibitory factor, interleukin-1β, and integrin beta-3 were increased in mice treated with either BMDCs, CXCL12, or both. The mRNA levels of matrix metalloproteinase-2 and -9 were significantly decreased by BMDCs but not by CXCL12. Pregnancy rates and litter size were increased after either treatment. Both BMDCs and CXCL12 displayed a comparable efficacy on endometrial regeneration in mice with thin endometrium. Our findings indicate the potential therapeutic effects of BMDCs and CXCL12 on infertility related to thin endometrium. Bone marrow-derived cells and CXCL12 displayed a comparable efficacy on endometrial regeneration in mice with thin endometrium.

Indexed as

Bone Marrow TransplantationInfertility, FemaleUterine DiseasesAnimalsBone Marrow CellsChemokine CXCL12Disease Models, AnimalEmbryo ImplantationEndometriumFemaleMiceMice, Inbred C57BLPregnancyChemokine CXCL12

Identifiers

PMID30084961
PMCPMC6335209
OpenAlexW2885156221

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.